These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 164313)

  • 1. Long-term therapy of viramin D-resistant richets with 25-hydroxycholecalciferol.
    Puschett JB; Genel M; Rastegar A; Anast C; DeLuca HF; Friedman A
    Clin Pharmacol Ther; 1975 Feb; 17(2):202-11. PubMed ID: 164313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid.
    Hirschman GH; DeLuca HF; Chan JC
    Pediatrics; 1978 Mar; 61(3):451-7. PubMed ID: 25411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D-dependency rickets in institutionalized, mentally retarded children on long term anticonvulsant therapy. II. The response to 25-hydroxycholecalciferol and to vitamin D2.
    Maclaren N; Lifshitz F
    Pediatr Res; 1973 Nov; 7(11):914-22. PubMed ID: 4356082
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of siblings with familial hypophosphatemic rickets.
    Lapatsanis PD; Sbyrakis S; Megreli C; Edelstein S
    Helv Paediatr Acta; 1983 Oct; 38(4):373-81. PubMed ID: 6654689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.
    Patel L; Clayton PE; Brain C; Pelekouda E; Addison GM; Price DA; Mughal MZ
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):687-96. PubMed ID: 8759181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D-resistant rickets and 25-hydroxycholecalciferol.
    Manis J; Norman A
    Br Med J; 1975 May; 2(5969):478-9. PubMed ID: 167901
    [No Abstract]   [Full Text] [Related]  

  • 10. 25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.
    Balsan S; Garabedian M
    J Clin Invest; 1972 Apr; 51(4):749-59. PubMed ID: 4335443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
    Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
    Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.
    Seino Y; Shimotsuji T; Ishida M; Ishii T; Yamaoka K; Yabuuchi H
    Contrib Nephrol; 1980; 22():101-6. PubMed ID: 6249540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE; Glorieux FH
    Calcif Tissue Int; 1981; 33(2):173-5. PubMed ID: 6260313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 19. [A sporadic case of vitamin D-resistant rickets in an adult].
    Chiesa A; Barbera G; Scassa E
    Minerva Med; 1983 Feb; 74(6):255-60. PubMed ID: 6298662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D-resistant rickets: clinical experience with 41 typical familial hypophosphatemic patients and 2 atypical nonfamilial cases.
    Stickler GB; Beabout JW; Riggs BL
    Mayo Clin Proc; 1970 Mar; 45(3):197-218. PubMed ID: 5435859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.